Page 380 - Binder2
P. 380
Complexity as Strategy
In biopharma, complexity has long been synonymous with
justification:
• For pricing that pushes $100,000 or more per year.
• For procedures that require clinical administration.
• For facilities that charge for space, staff, and
overhead.
• For intellectual property that extends not only to the
molecule, but to its mode of delivery.
Every layer of logistical difficulty—every point of contact
between drug and patient—creates an opportunity:
• To bill.
• To monitor.
• To control.
• To justify.
Access wasn’t just limited because of supply constraints or
scientific barriers. It was limited because that limitation
itself created value for the system—even if it degraded
value for the patient.
Friction as a Feature, Not a Flaw
When a patient needs:
• A doctor’s referral,
• A prior authorization,
• A cold-packed shipment,
• A hospital-based infusion chair…
378
